Mounjaro and Depression: What People on GLP-1 Medicines Are Noticing

The connection between medicines like Mounjaro (tirzepatide) and Wegovy (semaglutide) and mental health is an active area of research. GLP-1 receptors are found not only in the gut and pancreas but also in regions of the brain involved in mood, motivation, and emotional regulation — which is why researchers are interested in how these medicines may influence wellbeing beyond weight management.

What people commonly report

Experiences described by people on GLP-1 medicines fall into two broad (and seemingly opposite) categories:

• Improvements in mood: Some people describe feeling less emotionally driven around food, reduced anxiety connected to eating, and an overall lift in mood — possibly linked to positive changes in energy, sleep, or self-perception as their journey progresses.
• Low mood or depression-like symptoms: Others report feeling flat, emotionally withdrawn, or low — particularly in the early weeks of treatment or around dose changes. Fatigue, a common side effect, can also compound feelings of low mood.

What the evidence currently says

Regulatory agencies continue to monitor reports of mood and psychiatric symptoms for GLP-1 medicines. These medicines carry a Black Triangle (▼) designation in some countries, meaning that reporting any suspected side effects — including mood changes — to your national reporting scheme (such as the UK's Yellow Card scheme) is encouraged, in addition to speaking with your healthcare professional.

Depression on Mounjaro is not confirmed as a direct pharmacological effect, but it is something prescribers and researchers are actively looking at. If you are experiencing depression or significant mood changes while on Mounjaro, do not wait to raise it — contact your prescriber or doctor promptly.

For a deeper look at the research and lived experience around this topic, the page on Mounjaro and depression in more detail covers the evidence more fully. You can also find broader context about the medicine on the Mounjaro overview hub.

One of the most useful things you can do when mood feels uncertain is to start recording it consistently — not to self-diagnose, but to build a clear picture you can bring to your prescriber.

GLP Trackr's daily check-in lets you log mood and energy levels each day alongside other markers like sleep quality, food-noise, and water intake. Over time, this creates a visible pattern: you might notice that low mood clusters around a particular point in your weekly injection cycle, or that it correlates with poor sleep or lower protein intake. That kind of insight is difficult to spot from memory alone, but straightforward to see in the app's timeline.

The side-effect tracker lets you log specific symptoms — including emotional or psychological ones — so nothing gets forgotten between appointments. When you do speak with your prescriber, you can share a clear, dated record rather than trying to reconstruct how you were feeling weeks ago. GLP Trackr also lets you generate a doctor report summarising your logged data, which can make those conversations more productive.

If you are on your journey and want support from others navigating similar experiences, the in-app community connects you with other people on Mounjaro and Wegovy — because you are not on this journey alone. See also the page on what life looks like once you are on Mounjaro for more on managing the day-to-day experience.

Important: If you are experiencing persistent low mood, depression, or any thoughts of self-harm, please contact your healthcare professional promptly. GLP Trackr helps you record and reflect on your experience — it is not a substitute for clinical support, and mood changes during treatment always warrant a conversation with your prescriber or doctor.

Start logging your mood and side effects today — GLP Trackr is free to try for 7 days on the App Store and Google Play.